Contineum Therapeutics, Inc. Class A Common Stock
About
Contineum Therapeutics, Inc. Class A Common Stock (NASDAQ:CTNM) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 5 2026
Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
Mar 3 2026
Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare Conference
Jan 28 2026
Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Dec 12 2025
Contineum Therapeutics Announces Pricing of Upsized $90.0 Million Public Offering
Dec 11 2025
Contineum Therapeutics Announces Proposed $75.0 Million Public Offering
Financials
Revenue
$0
Market Cap
$479.02 M
EPS
-2.17